MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Rectal Adenocarcinoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin

Key details

Phase

Early testing

Sponsor

Medical College of Wisconsin

Enrollment target

~22 participants

Started

June 2021

Primary completion

April 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer — Stella